• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assays
      • Transcreener® ADP² Kinase Assay
      • Transcreener® ADO CD73 Assay
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay
      • Transcreener® cGAMP cGAS Assay
      • Transcreener® EPIGEN SAH Methyltransferase Assay
      • Transcreener® GDP GTPase Assay Kits
      • Transcreener® UDP² Glycosyltransferase Assay
      • Transcreener® 2-5A OAS Assay
    • AptaFluor® HTS Assays
      • AptaFluor® SAH Methyltransferase Assay
    • HTS Assays by Target Family
      • Kinase Assay Kits
      • ATPase Assay Kits
      • Glycosyltransferase Assay Kits
      • GTPase Assay Kits
        • GAP Assay Kits
        • GEF Assay Kits
      • Ligase and Synthetase Assay Kits
      • Methyltransferase Assay Kits
      • Phosphodiesterase Assay Kits
    • HTS Assays by Target
      • Adenosine Kinase Assay Kits
      • AMPK Assay Kits
      • CD39 Assay Kits
      • CD73 Assay Kits
      • cGAS Assay Kits
      • DDX3 Assay Kits
      • ENPP1 Assay Kits
      • EZH2 Assay Kits
      • IKK-beta Assay Kits
      • IRAK4 Assay Kits
      • JAK1 Assay Kits
      • JAK3 Assay Kits
      • NSP13 Assay Kits
      • NUDT5 Assay Kits
      • OAS Assay Kits
      • TBK1 Assay Kits
    • Recombinant Enzymes
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
      • Human DDX3 Enzyme
      • Human OAS1 Enzyme
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • CD38 Assay Services
    • GTPase Profiling Services
  • Innate Immunity
    • Adenosine Kinase Activity Assays
    • AMPK Activity Assays
    • cGAS Activity Assays
    • CD73 Activity Assays
    • CD38 Activity Assay Services
    • CD39 Activity Assays
    • DDX3 Activity Assays
    • ENPP1 Activity Assays
    • IKK-beta Activity Assays
    • IRAK4 Activity Assays
    • JAK1 Activity Assays
    • JAK3 Activity Assays
    • NSP13 Activity Assays
    • OAS1 Activity Assays
    • TBK1 Activity Assays
  • Resources
    • Technical Manuals
    • Transcreener® Assays – Instrument Compatibility
    • Application Notes
    • Posters and Presentations
    • Publications
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
      • Kinases in Innate Immunity
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

Helping Fight Ovarian Cancer with ST3GAL1 Inhibitors

by Bellbrook Labs / Monday, 11 November 2019 / Published in HTS Assays
Fighting Ovarian Cancer ST3GAL1 Inhibitors

Important functions such as cell–cell recognition, protein targeting, and cell adhesion taking place in the human body get carried out through a process known as sialylation. Sialylation is a common reaction that is catalyzed by a sialyltransferase (ST) enzyme with the goal of adding a sialic acid (monosaccharide) to a growing oligosaccharide forming a glycolipid or glycoprotein.

These same functions along with many others are negatively impacted in cancer patients leading to tumor progression and metastasis. Therefore, it comes as no shock that individuals with cancer have an abnormally high level of sialyltransferases (STs).

There are multiple types of STs named based on the linkage and function; specifically, their attachment of sialic acid to various terminal positions on a glycoprotein. For example, Beta-galactoside alpha-2,3-sialyltransferase 1 (ST3GAL1) is named as such due to the transfer of sialic acid from cytidine monophosphate-sialic acid to galactose-containing substrates.

Contribution of ST3GAL1 in Ovarian Cancer

Researchers have found an increased level of ST3GAL1 in ovarian cancers, which has been associated with resistance to chemotherapy and tumor progression.2

Since hypersialylation has been associated with metastatic cell behavior including invasion and enhanced cell survival, finding a ST3GAL1 inhibitor would be useful in preventing metastasis which is extremely necessary in ovarian cancer.2 Typically, the disease has progressed and metastasized by the time it is diagnosed due to no specific symptoms or easy, reliable detection methods.

Of all cancers, ovarian is the fifth leading in cancer-related deaths.1 As with many cancer types, there’s a higher survival rate if the disease is found early, and proper treatment occurs.

ST3GAL1 Inhibitor Assay 

Researchers have found a decrease in cell growth, migration, and invasion when ST3GAL1 is knockdown in ovarian cancer tissue culture cells.2 While the search is on for discovering ST3GAL1 inhibitors in order to battle cancer, there is still much to learn. The Transcreener® AMP2/GMP2 Assay is capable of detecting ST3GAL1 activity through direct detection of CMP. The enzyme converts CMP-sialic acid to sialic acid in order to create a galactose-containing substrate, forming CMP as a product that can be measured by using a specific antibody and tracer labeled with a fluorophore. This advantageous method can assist in the drug discovery by providing an HTS capable screening tool, and an effort to find ST3GAL1 inhibitors as an ovarian cancer treatment.

References

  1. Coleman RL, Hennessy BT, Coleman RL, Markman M. Ovarian cancer. 2015;6736(June):433-440. doi:10.1016/S0140-6736(09)61338-6
  2. Wu X, Zhao J, Ruan Y, Sun L, Xu C, Jiang H. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer. Cell Death Dis. 2018;9(11). doi:10.1038/s41419-018-1101-0
Tagged under: ST3GAL1 Inhibitors, Transcreener AMP/GMP Assay, Transcreener CMP Assay

What you can read next

malignant adenocarcinoma could be treated by NUDT5 Inhibitors
Exploring the Use of NUDT5 Inhibitors to Treat Breast Cancer
Creating a Methyltransferase HTS Assay Using an SAH Riboswitch Part II
Kinase Assays and Applications in Cancer Therapeutic Discovery

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Innate Immunity
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • Scientist Studying ALKPK1

    The Role ALPK1 in Health and Disease

    ALPK1 (Alpha Kinase 1) is an atypical serine/th...
  • DHX36 RNA Helicase Unwinds G4 RNA Structures

    Resolving the Many Roles of DHX36

    While most researchers are familiar with canoni...
  • Researcher Studying MAPK14

    MAPK14 in Context

    MAPK14 (or p38 alpha or SAPK2a) is a proline-di...
  • PRMT5 Role with Macrophages

    PRMT5 is Innately Interesting

    PRMT5 is a type II arginine methyltransferase t...
  • IRE1 Proteins in ER

    The Multifaceted Roles of IRE1 Are Unfolding

    IRE1 (Inositol-Requiring Enzyme 1) is one of th...

Archives

BellBrook Labs
5500 Nobel Drive, Suite 230
Madison, Wisconsin 53711 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2021 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP